Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Symptom severity | |||||
Systematic review |
40 people Data from 1 RCT |
Mean difference in Brief Psychiatric Rating Scale (BPRS) total score at endpoint
short term
with risperidone (4 mg/day) with zotepine (225 mg/day) Absolute results not reported |
Mean difference +1.40 95% CI –9.82 to +12.62 |
Not significant | |
Systematic review |
40 people Data from 1 RCT |
Mean difference in BPRS total score at endpoint
short term
with risperidone (8 mg/day) with zotepine (225 mg/day) Absolute results not reported |
Mean difference –1.30 95% CI –12.95 to +10.35 |
Not significant | |
Systematic review |
40 people Data from 1 RCT |
No improvement in cognitive functioning (SKT)
short term
with risperidone (4 mg/day) with zotepine (225 mg/day) Absolute results not reported |
RR 0.80 95% CI 0.25 to 2.55 |
Not significant | |
Systematic review |
40 people Data from 1 RCT |
No improvement in cognitive functioning (SKT)
short term
with risperidone (8 mg/day) with zotepine (225 mg/day) Absolute results not reported |
RR 1.00 95% CI 0.29 to 3.45 |
Not significant |